Showing results (31-40 of 91) with videos related to
Sort By:
Pageof 10
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.Leukemia & Lymphoma|May 7, 2015
Analysis of class I and II histone deacetylase gene expression in human leukemiaHui Yang, Sirisha Maddipoti, Andres Quesada, et al.Nature|December 3, 2010
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cellsBoyi Gan, Jian Hu, Shan Jiang, et al.Blood|October 24, 2002
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone diseaseNicola Giuliani, Simona Colla, Roberto Sala, et al.Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.European Journal of Haematology|April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemiaSimona Colla, Gabriella Sammarelli, Monica Crugnola, et al.Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.Blood Advances|March 23, 2019
Subclonal STAT3 mutations solidify clonal dominanceCassandra M Kerr, Michael J Clemente, Peter W Chomczynski, et al.Nature Medicine|March 4, 2022
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.Pageof 10